Form 4: Hanover Bancorp Director Receives Restricted Stock Grant

Hanover Bancorp, Inc. Director Michael David Katz M.D. was granted 1,592 shares of restricted common stock vesting over three years.

Summary

• Director Michael David Katz M.D. of Hanover Bancorp, Inc. (HNVR) was granted 1,592 shares of common stock on February 5, 2026.
• The grant represents restricted stock subject to forfeiture, with a vesting schedule over three years.
• One-third of the granted shares will vest on March 1, 2027, another one-third on March 1, 2028, and the final one-third on March 1, 2029.
• Following this transaction, Dr. Katz directly beneficially owns 152,202 shares and indirectly owns 96,825 shares through custodians for grandchildren and a trust, totaling 249,027 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard director compensation practices and a continued alignment of interests between the director and shareholders through long-term equity incentives.

Positives

• The grant of restricted stock aligns the director's interests with long-term shareholder value.
• Increased beneficial ownership by a director can signal confidence in the company's future prospects.

Risks

• The restricted stock is subject to forfeiture, meaning the director may not fully realize the value if vesting conditions, such as continued employment, are not met.

Future Outlook

The restricted stock grant indicates a future commitment to the company by the director, with vesting scheduled through March 2029, aligning long-term incentives and retention.

Industry Context

StockSavvy.ai notes that restricted stock grants are a common form of equity compensation for directors and executives in the banking industry, used to incentivize long-term performance and retention. This practice is standard across publicly traded financial institutions.

Comparison to Industry Standards

• Restricted stock grants are a standard component of director compensation packages across the financial services industry, comparable to practices at regional banks like Flushing Financial Corporation (FFIC) or ConnectOne Bancorp, Inc. (CNOB).
• The three-year vesting schedule is typical for such grants, aiming to align director interests with sustained company performance over a multi-year horizon.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with long-term shareholder value, potentially leading to more focused governance and strategic decisions.
• Director: The director receives equity compensation, incentivizing continued service and performance, subject to vesting conditions.

Next Steps

• First vesting of approximately 531 shares on March 1, 2027.
• Second vesting of approximately 530 shares on March 1, 2028.
• Third and final vesting of approximately 530 shares on March 1, 2029.

Key Dates

Recommendation

This Form 4 filing details a routine restricted stock grant to a director, which is a standard compensation practice. It does not present new information that would fundamentally alter the investment thesis for Hanover Bancorp, Inc. While it shows continued alignment of interests, it is not a catalyst for a 'buy' or 'sell' recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Hanover Bancorp, HNVR, Michael David Katz, Restricted Stock, Stock Grant, Director Compensation, Beneficial Ownership, SEC Form 4, Equity Compensation